Upgrade to SI Premium - Free Trial

EU panel backs Datroway for metastatic breast cancer patients

June 26, 2026 7:01 AM
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Datroway (datopotamab deruxtecan) as ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA